Li Yuejun, Gong Lili, Qi Ruili, Sun Qian, Xia Xinxin, He Haihui, Ren Jianshu, Zhu Ouning, Zhuo Debin
The Third Department of Oncology, The First Affiliated Hospital of Hunan College of Traditional Chinese Medicine, Zhuzhou, Hunan.
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong.
Drug Des Devel Ther. 2017 Aug 23;11:2481-2491. doi: 10.2147/DDDT.S134518. eCollection 2017.
Paeoniflorin (PF) is an active monoterpene glycoside extracted from Pall. PF has exhibited antitumor effects in various cancer types. However, the effects of PF in pancreatic cancer are largely unexplored. Here, we showed that PF suppressed growth of pancreatic cancer cell lines Capan-1 and MIAPaCa-2 and profoundly sensitized these cells to X-ray irradiation. Through microarray analysis, we identified HTRA3, a tumor-suppressor candidate gene, as the most increased gene upon PF treatment in Capan-1 cells. Ectopic expression of HTRA3 led to reduced cell proliferation and increased expression of apoptotic protein Bax, suggesting a tumor suppressive role of HTRA3 in pancreatic cancer cells. Together, our results provide a set group of genetic proofs and biological proofs that PF inhibited pancreatic cancer growth by upregulating HTRA3.
芍药苷(PF)是从芍药中提取的一种活性单萜糖苷。PF在多种癌症类型中均表现出抗肿瘤作用。然而,PF在胰腺癌中的作用在很大程度上尚未得到探索。在此,我们表明PF抑制胰腺癌细胞系Capan-1和MIAPaCa-2的生长,并使这些细胞对X射线照射高度敏感。通过微阵列分析,我们确定了肿瘤抑制候选基因HTRA3是PF处理后Capan-1细胞中表达增加最多的基因。HTRA3的异位表达导致细胞增殖减少和凋亡蛋白Bax表达增加,表明HTRA3在胰腺癌细胞中具有肿瘤抑制作用。总之,我们的结果提供了一组遗传学证据和生物学证据,证明PF通过上调HTRA3抑制胰腺癌生长。